Kavitha Yaddanapudi Department of Surgery University of Louisville Biography Publications Institution JoVE Articles Kavitha Yaddanapudi has not added a biography. If you are Kavitha Yaddanapudi and would like to personalize this page please email our Author Liaison for assistance. Publications Cancer Vaccines: Promising Therapeutics or an Unattainable Dream Vaccines. Jun, 2021 | Pubmed ID: 34207062 Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope Frontiers in Immunology. 2020 | Pubmed ID: 32765528 Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) MRNA Content Using Primary Melanocyte SEVs As a Reference International Journal of Molecular Sciences. Mar, 2019 | Pubmed ID: 30870978 Simultaneous Quantification of Nucleosides and Nucleotides from Biological Samples Journal of the American Society for Mass Spectrometry. Jun, 2019 | Pubmed ID: 30847833 Exosomes from GM-CSF Expressing Embryonic Stem Cells Are an Effective Prophylactic Vaccine for Cancer Prevention Oncoimmunology. 2019 | Pubmed ID: 30723593 Vaccination with Induced Pluripotent Stem Cells Confers Protection Against Cancer Stem Cell Investigation. 2018 | Pubmed ID: 30148156 Temozolomide Renders Murine Cancer Cells Susceptible to Oncolytic Adenovirus Replication and Oncolysis Cancer Biology & Therapy. 03, 2018 | Pubmed ID: 29252087 Myeloid-derived Suppressor Cells-a New Therapeutic Target to Overcome Resistance to Cancer Immunotherapy Journal of Leukocyte Biology. 09, 2017 | Pubmed ID: 28546500 The Soy-derived Peptide Lunasin Inhibits Invasive Potential of Melanoma Initiating Cells Oncotarget. Apr, 2017 | Pubmed ID: 28424421 Validation of Syngeneic Mouse Models of Melanoma and Non-small Cell Lung Cancer for Investigating the Anticancer Effects of the Soy-derived Peptide Lunasin F1000Research. 2016 | Pubmed ID: 28299174 Lunasin is a Novel Therapeutic Agent for Targeting Melanoma Cancer Stem Cells Oncotarget. Dec, 2016 | Pubmed ID: 27566591 MIF Inhibition Reverts the Gene Expression Profile of Human Melanoma Cell Line-induced MDSCs to Normal Monocytes Genomics Data. Mar, 2016 | Pubmed ID: 26981417 MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation Cancer Immunology Research. Feb, 2016 | Pubmed ID: 26603621 The Soybean-derived Peptide Lunasin Inhibits Non-small Cell Lung Cancer Cell Proliferation by Suppressing Phosphorylation of the Retinoblastoma Protein Oncotarget. Mar, 2015 | Pubmed ID: 25609198 Stromal-dependent Tumor Promotion by MIF Family Members Cellular Signalling. Dec, 2014 | Pubmed ID: 25277536 MIF Family Members Cooperatively Inhibit P53 Expression and Activity PloS One. 2014 | Pubmed ID: 24932684 Cancer Vaccines: Looking to the Future Oncoimmunology. Mar, 2013 | Pubmed ID: 23802081 Control of Tumor-associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor Journal of Immunology (Baltimore, Md. : 1950). Mar, 2013 | Pubmed ID: 23390297 Multi-peptide Immunotherapeutic Vaccine for Renal Cell Carcinoma: Getting the Troops All Worked Up Translational Andrology and Urology. Dec, 2012 | Pubmed ID: 25221745 Negative Regulation of AMP-activated Protein Kinase (AMPK) Activity by Macrophage Migration Inhibitory Factor (MIF) Family Members in Non-small Cell Lung Carcinomas The Journal of Biological Chemistry. Nov, 2012 | Pubmed ID: 22988252 Vaccination with Embryonic Stem Cells Protects Against Lung Cancer: is a Broad-spectrum Prophylactic Vaccine Against Cancer Possible? PloS One. 2012 | Pubmed ID: 22860107 Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells Shuhan Meng1,2, Aaron G. Whitt1,2,3, Allison Tu2, John W. Eaton1,2,3, Chi Li1,2,3, Kavitha Yaddanapudi4,5,6 1Department of Pharmacology and Toxicology, University of Louisville, 2Experimental Therapeutics Program, Brown Cancer Center, University of Louisville, 3Department of Medicine, University of Louisville, 4Department of Surgery, University of Louisville, 5Immuno-Oncology Program, Brown Cancer Center, University of Louisville, 6Department of Microbiology and Immunology, University of Louisville JoVE 60170 Cancer Research Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells Connor S. Centner1, Emily M. Murphy1, Bryce F. Stamp2, Mariah C. Priddy1, John T. Moore1, Paula J. Bates2, Michael A. Menze3, Kavitha Yaddanapudi2, Jonathan A. Kopechek1 1Department of Bioengineering, University of Louisville, 2School of Medicine, University of Louisville, 3Department of Biology, University of Louisville JoVE 62035 Bioengineering
Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells Shuhan Meng1,2, Aaron G. Whitt1,2,3, Allison Tu2, John W. Eaton1,2,3, Chi Li1,2,3, Kavitha Yaddanapudi4,5,6 1Department of Pharmacology and Toxicology, University of Louisville, 2Experimental Therapeutics Program, Brown Cancer Center, University of Louisville, 3Department of Medicine, University of Louisville, 4Department of Surgery, University of Louisville, 5Immuno-Oncology Program, Brown Cancer Center, University of Louisville, 6Department of Microbiology and Immunology, University of Louisville JoVE 60170 Cancer Research
Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells Connor S. Centner1, Emily M. Murphy1, Bryce F. Stamp2, Mariah C. Priddy1, John T. Moore1, Paula J. Bates2, Michael A. Menze3, Kavitha Yaddanapudi2, Jonathan A. Kopechek1 1Department of Bioengineering, University of Louisville, 2School of Medicine, University of Louisville, 3Department of Biology, University of Louisville JoVE 62035 Bioengineering
